Atlas Trials

Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer

Clinical trial NCT01980277 · TERMINATED

Trial details

NCT number
NCT01980277
Sponsor
Institut Paoli-Calmettes
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-01-01
Primary completion
2017-05-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.